+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005



Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005



Sexually Transmitted Diseases 41(1): 46-49



There are limited data on the proportion who have been exposed to vaccine-type human papillomavirus (HPV) among women attending sexually transmitted disease (STD) clinics; this information could inform the potential benefits of HPV vaccination for women attending this venue. Human papillomavirus surveillance was conducted in STD clinics in Baltimore, MD; Boston, MA; Denver, CO; Los Angeles, CA; and Seattle, WA, among women receiving cervical cancer screening from January 2003 to December 2005. The women had specimens collected for cervical cytology HPV testing by L1 consensus polymerase chain reaction testing and serologic assessment for HPV 6, 11, 16, and 18 using the competitive Luminex immunoassay. Results from 880 women with adequate specimens were included. Women were HPV naïve if they were both HPV DNA negative and seronegative for a specific HPV type. One hundred seventy women (19.3%) had HPV 16, 18, 6, or 11 DNA, and 418 (47.5%) were HPV 16, 18, 6, or 11 seropositive. Four hundred ten (46.6%) women were naïve to all 4 types, 570 (64.8%) were naïve to both HPV 16 and 18, and 545 (61.9%) were naïve to both HPV 6 and 11. Almost all (99.3%) women were naïve to at least 1 vaccine HPV type. Almost half of young women age eligible for HPV vaccine and attending STD clinics were naïve to all 4 HPV types, and more than half were naïve to both HPV 16 and 18. This assessment suggests that most young women attending this venue might benefit from HPV vaccination.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056963797

Download citation: RISBibTeXText

PMID: 24326582

DOI: 10.1097/olq.0000000000000071


Related references

Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. Journal of Infectious Diseases 190(9): 1563-1574, 2004

The spectrum of genital human papillomavirus infection among men attending a Swedish sexually-transmitted infections clinic: human papillomavirus typing and clinical presentation of histopathologically benign lesions. Acta Dermato-Venereologica 93(2): 223-227, 2013

Prevalence of human papillomavirus infection in women attending a sexually transmitted disease clinic. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 73(3): 233-238, 1999

Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study. Lancet. Infectious Diseases 15(11): 1314-1323, 2016

Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women. International Journal of Gynecological Cancer 21(8): 1486-1490, 2012

Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women. Human Vaccines and Immunotherapeutics 2019, 2019

Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstetrics and Gynecology 111(5): 1103-1110, 2008

Human papillomavirus infection in men attending a sexually transmitted disease clinic. Journal of Infectious Diseases 187(7): 1064-1070, 2003

Comparison of the AdvanSure human papillomavirus screening real-time PCR, the Abbott RealTime High Risk human papillomavirus test, and the Hybrid Capture human papillomavirus DNA test for the detection of human papillomavirus. Annals of Laboratory Medicine 32(3): 201-205, 2012

Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature. International Journal of Dermatology 57(6): 627-634, 2017

Human papillomavirus infection among sexual partners attending a Sexually Transmitted Disease Clinic in Rio de Janeiro, Brazil. Brazilian Journal of Medical and Biological Research 46(6): 533-538, 2014

Epidemiological investigation of human papillomavirus infection in men attending a sexually transmitted disease clinic in Hangzhou area. Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi 20(1): 4-7, 2006

Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sexually Transmitted Diseases 31(10): 601-607, 2004

High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus. Aids 30(3): 425-433, 2016

Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data. Medical Journal of Australia 206(5): 204-209, 2017